Company Filing History:

19 out of 220

Pharmacia Corporation

patents

14 out of 1,323

G.d. Searle & Company

Pharmacia Corporation Global Patent Department

patent

Years Active: 1998-2010

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),

2. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),

3. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),

4. 7119203 - Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors (2006-10-10),

5. 6890928 - Aromatic sulfone hydroxamic acids and their use as protease inhibitors (2005-05-10),

6. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),

7. 6765023 - Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-07-20),

8. 6723753 - Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

9. 6723752 - (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

10. 6710089 - Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-23),

11. 6699898 - Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-02),

12. 6696472 - Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

13. 6696435 - Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

14. 6689794 - Aromatic sulfone hydroxamates and their use as protease inhibitors (2004-02-10),

15. 6683113 - (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-01-27),

Title: Inventor Monica B Norton - Revolutionizing Technology in St. Louis

Introduction: Monica B Norton is a pioneering inventor based in St. Louis, Missouri, known for her groundbreaking contributions to the field of technology. With a passion for innovation and a drive to create solutions that make a difference, she has established herself as a prominent figure in the industry.

Latest Patents: Monica B Norton's latest patents focus on cutting-edge advancements in artificial intelligence and sustainable energy solutions. Her innovative ideas have led to the development of technologies that are shaping the future of various sectors.

Career Highlights: Throughout her illustrious career, Monica B Norton has received numerous accolades for her inventive spirit and dedication to progress. Her work has not only transformed industries but has also inspired a new generation of inventors to push the boundaries of what is possible.

Collaborations: Monica B Norton has collaborated with leading tech companies and research institutions to bring her ideas to life. By fostering partnerships with like-minded innovators, she has been able to leverage collective expertise and resources to drive innovation forward.

Conclusion: In conclusion, Monica B Norton's impact on the world of technology is undeniable. Her relentless pursuit of innovation and commitment to excellence continue to shape the landscape of inventions, making her a true trailblazer in her field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com